Hood River Capital Management LLC Esperion Therapeutics, Inc. Transaction History

Hood River Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $7.79 Million - $11.4 Million	-310,070 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $1.19 Million - $1.75 Million	49,058 Added 18.8%	310,070 $8.06 Million
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $3.46 Million - $5.85 Million	-110,952 Reduced 29.83%	261,012 $9.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $499,745 - $853,593	16,636 Added 4.68%	371,964 $19.1 Million
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $2.35 Million - $6.31 Million	85,483 Added 31.68%	355,328 $11.2 Million
Q4 2019 Feb 13, 2020	BUY	$35.4 - $59.82 $9.55 Million - $16.1 Million	269,845 New	269,845 $16.1 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.